Company Number: 12644016

Analysis Date: 2025-07-29 12:58 UTC

Financial Health Assessment for MY CARIAD LIMITED as of 30 June 2024

---

1. Financial Health Score: D

Explanation:
MY CARIAD LIMITED exhibits significant financial distress indicated by persistent negative net assets and net current liabilities over multiple years. The company has a weak liquidity position and negative shareholders' equity, which are symptoms of financial strain. While the company remains active and compliant with filings, the ongoing deficit suggests urgent remedial action is needed.

---

2. Key Vital Signs:

Metric	2024 Value	Interpretation
Current Assets	£21,344	Low current assets relative to liabilities; limited liquidity.
Cash at Bank	£2,044	Very low cash reserves; not enough to cover short-term debts.
Current Liabilities	£60,355	High short-term obligations; significant pressure on cash flow.
Net Current Assets (Working Capital)	-£39,011	Negative working capital signals insufficient short-term resources to cover liabilities.
Net Assets (Shareholders’ Funds)	-£39,011	Negative equity indicates accumulated losses and creditor exposure exceeding assets.
Directors' Loan Account	£59,834	Large debt owed to directors, possibly propping up operations.

Additional Observations:

• Stock levels remain steady at approx. £19,300 but represent a large portion of current assets, which may be illiquid.
• Share capital is nominal (£1), showing minimal shareholder investment.
• No audit required (small company exemption), limiting external financial scrutiny.

---

3. Diagnosis:

MY CARIAD LIMITED is showing classic symptoms of a company in financial distress. The persistent negative net assets and working capital deficits over consecutive years reveal an imbalance where current liabilities significantly exceed current assets. This condition is akin to a patient whose vital signs (cash flow and liquidity) are weak, signaling that the company may struggle to meet short-term obligations without external support.

The large directors’ loan account suggests the company is reliant on internal funding to sustain operations, which could be a temporary life-support measure rather than a long-term solution. The low cash balance compared to high liabilities indicates “cash flow anemia,” making it difficult to cover immediate debts, risking creditor pressure or insolvency if not addressed.

While the company continues to operate and file accounts on time, the financial position is precarious and warrants immediate attention to avoid worsening conditions.

---

4. Recommendations:

1. Liquidity Improvement Plan:

   • Prioritize converting stock into cash through sales promotions or discounts to improve cash availability.
   • Review credit terms with suppliers and negotiate extensions to ease short-term cash demands.
   • Explore options for external financing or capital injection to reduce reliance on directors’ loans.

2. Cost Management and Cash Flow Monitoring:

   • Implement strict cost controls to limit overheads and non-essential expenses.
   • Establish a rolling cash flow forecast to identify potential shortfalls early and manage payments proactively.

3. Debt Restructuring:

   • Engage with creditors, including directors, to restructure loan terms, potentially converting some debt to equity or extending repayment periods.

4. Financial Strategy Review:

   • Consider a strategic review of business operations, sales channels, and pricing to improve margins and overall profitability.
   • Investigate opportunities for new revenue streams or business pivots aligned with market demand.

5. Professional Financial Advice:

   • Seek guidance from insolvency practitioners or financial advisors to explore turnaround strategies and prevent insolvency risks.

---

Executive Summary:

MY CARIAD LIMITED is currently in a fragile financial state characterized by significant negative net assets and working capital deficits, indicating financial stress. Immediate actions focusing on liquidity improvement, cost control, and debt restructuring are crucial to stabilize operations and avoid insolvency risks. Without decisive intervention, the company's financial health is unlikely to improve.